492 related articles for article (PubMed ID: 21784468)
21. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis.
Tang K; Xu H
Sci Rep; 2015 May; 5():10272. PubMed ID: 25974855
[TBL] [Abstract][Full Text] [Related]
23. Identification of a microRNA panel for clear-cell kidney cancer.
Juan D; Alexe G; Antes T; Liu H; Madabhushi A; Delisi C; Ganesan S; Bhanot G; Liou LS
Urology; 2010 Apr; 75(4):835-41. PubMed ID: 20035975
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
25. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.
Xu X; Jia R; Zhou Y; Song X; Wang J; Qian G; Ge S; Fan X
Int J Oncol; 2011 May; 38(5):1385-93. PubMed ID: 21373755
[TBL] [Abstract][Full Text] [Related]
26. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs: potential regulators involved in human anencephaly.
Zhang Z; Chang H; Li Y; Zhang T; Zou J; Zheng X; Wu J
Int J Biochem Cell Biol; 2010 Feb; 42(2):367-74. PubMed ID: 19962448
[TBL] [Abstract][Full Text] [Related]
28. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
29. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
[TBL] [Abstract][Full Text] [Related]
32. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
33. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
35. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma.
Girgis AH; Iakovlev VV; Beheshti B; Bayani J; Squire JA; Bui A; Mankaruos M; Youssef Y; Khalil B; Khella H; Pasic M; Yousef GM
Cancer Res; 2012 Oct; 72(20):5273-84. PubMed ID: 22926558
[TBL] [Abstract][Full Text] [Related]
36. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
37. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
Duns G; van den Berg A; van Dijk MC; van Duivenbode I; Giezen C; Kluiver J; van Goor H; Hofstra RM; van den Berg E; Kok K
Genes Chromosomes Cancer; 2013 Feb; 52(2):165-73. PubMed ID: 23074016
[TBL] [Abstract][Full Text] [Related]
38. miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma.
Zhang A; Liu Y; Shen Y; Xu Y; Li X
Urology; 2011 Aug; 78(2):474.e13-9. PubMed ID: 21820586
[TBL] [Abstract][Full Text] [Related]
39. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
[TBL] [Abstract][Full Text] [Related]
40. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]